Αποτελέσματα Αναζήτησης
Since 1996, Cardinal Partners has been investing in disruptive healthcare technology-enabled services and life sciences companies providing top quartile returns.
- Team
The operating and investment backgrounds of the Cardinal’s...
- Companies
Cardinal Partners is lead investor, raising capital and IPO...
- Our Vision
The transition from paper to digital combined with machine...
- Contact
Princeton Office (HQ) 230 Nassau Street, Princeton, NJ 08542...
- Venture Partners
Venture Partners; Venture Partners Together we can achieve...
- John Clarke
John Clarke has a 35 year record of early-stage venture...
- Thomas Mckinley
Thomas McKinley has over 35 years of venture capital...
- Events
© 2019 Cardinal Partners. All rights reserved. Scroll to top
- Team
Cardinal Partners is a venture capital partnership focused exclusively on healthcare investing.
Cardinal Partners is lead investor, raising capital and IPO process, assisting with strategic partnerships and M&A. Verastem is focusing on a portfolio of small molecule drugs inhibiting critical signaling pathways in cancer, including the phosphoinositide 3-kinase (PI3K) and focal adhesion kinase (FAK) pathways.
John Clarke has a 35 year record of early-stage venture capital investment success. John co-founded Cardinal Partners in 1997 and currently serves as a Managing Partner of the firm. John leads Cardinal’s life sciences investment efforts and has had an extraordinary record of success.
Founded in 1996, Cardinal Partners is a venture capital firm based in Princeton, New Jersey. The firm prefers to invest in the healthcare, consumer, machine learning, blockchain, technology, and life sciences sectors. This firm is a Registered Investment Adviser (RIA).
Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies | Cardinal Partners has extensive experience in starting, incubating and investing...
Cardinal Partners operates as a venture capital firm. The Company invests in biotechnology, medical devices, and information technology and services sectors.